Cargando…
Diffuse large B-cell lymphoma (DLBCL) : symptoms, treatment and prognosis /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Biomedical/Nova Science Publishers, Inc.,
[2016]
|
| Colección: | Cancer etiology, diagnosis, and treatments.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) SYMPTOMS, TREATMENT AND PROGNOSIS ; DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) SYMPTOMS, TREATMENT AND PROGNOSIS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 Pathologic Diagnosis and Prognostic Markers of Diffuse Large B-Cell Lymphoma; Abstract; Introduction; Epidemiology and Clinical Features; Morphologic and Immunophenotypic Features; Differential Diagnosis; Genetic and Molecular Features; Prognostic Markers; Morphologic Subtypes and Other Entities; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
- Primary DLBCL of the Central Nervous SystemPrimary Cutaneous DLBCL, Leg Type; EBV-Positive DLBCL of the Elderly; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Intravascular Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation; Lymphomatoid Granulomatosis; ALK-Positive Large B-Cell Lymphoma; Plasmablastic Lymphoma; Diffuse Large B-Cell Lymphoma with IG/IRF4 Translocation; Large B-Cell Lymphoma Arising in HHV8-Associated Multicentric Castleman Disease; Primary Effusion Lymphoma
- B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Classical Hodgkin LymphomaB-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Burkitt Lymphoma; References; Chapter 2 Diffuse Large B-Cell Lymphoma: Diagnosis, Treatment and Prognosis; Abstract; Introduction; Clinical Presentation of DLBCL; Prognosis of DLBCL; Pathologic Characteristics and Classification of DLBCL; DLBCL, Not Otherwise Specified (NOS); Primary Mediastinal Large B-Cell Lymphoma (PMBCL); T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; EBV-Positive DLBCL
- DLBCL in Specific Anatomic SitesDLBCL with Plasma Cell Immunophenotype; B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Burkitt Lymphoma; B-Cell Lymphoma, Unclassifiable, with Features Intermediate between DLBCL and Hodgkin Lymphoma; Treatment of DLBCL; Current Standard of Care: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP); Treatment of Older Adults; Treatment of Patients with Cardiac Dysfunction; HIV-Associated Lymphomas; Primary Mediastinal Large B-Cell Lymphoma; Relapsed/Refractory DLBCL
- Future Directions in the Treatment of DLBCLTargeted Therapies for Surface Markers in DLBCL; Targeted Therapies for GCB-Type DLBCL; Targeted therapies for ABC-Type DLBCL; Chimeric Antigen Receptor T (CAR T)-Cell Therapy; Conclusion; References; Chapter 3 The Evolving Role of Radiation Therapy in the Management of Diffuse Large B-Cell Lymphoma; Abstract; Introduction; The Era of Chop; Prospective Trials; Retrospective Studies; R-CHOP Studies; Advanced Stage; Prospective Evaluation in the Era of R-CHOP; Radiation Techniques; Risk-Adapted Treatment Selection; Conclusion; References